Evidence map›Paper›PMID 41159034›Full record

ArticleFrontiers in immunology2025

Colonization by

Daniel Peipert, Theresa L Montgomery, Lucinda C Toppen, Margaret Frances J Lee, Matthew J Scarborough, Dimitry N Krementsov

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel PeipertDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, VT, United States.
Theresa L MontgomeryDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, VT, United States.
Lucinda C ToppenDepartment of Civil and Environmental Engineering, University of Vermont, Burlington, VT, United States.
Margaret Frances J LeeDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT, United States.
Matthew J ScarboroughDepartment of Civil and Environmental Engineering, University of Vermont, Burlington, VT, United States.
Dimitry N KrementsovDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, VT, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Multiple sclerosis is autoimmune disease of the central nervous system (CNS) in which myelin-reactive immune attack drives demyelination and subsequent disability. Various studies have documented elevated abundance of the commensal gut bacterium Methods: To address this possibility, we generated two distinct microbiome models in C57BL/6J mice, each stably colonized by Results: We found that Discussion: Taken together, our data suggest that the effect of

Indexed as

AutoimmunityCentral Nervous SystemEncephalomyelitis, Autoimmune, ExperimentalGastrointestinal MicrobiomeMultiple SclerosisVerrucomicrobiaAkkermansiaAnimalsDisease Models, AnimalFemaleMiceMice, Inbred C57BLAkkermansia muciniphilaexperimental autoimmune encephalomyelitis (EAE)fibergut microbiomemetabolitesmultiple sclerosis (MS)short-chain fatty acid (SCFA)

Identifiers

PMID41159034
PMCPMC12557997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.